Managing alcoholic liver disease
Alcoholic liver disease continues to be a significant cause of liver-related morbidity and mortality throughout the world. A number of diagnostic and prognostic models have been developed in the management of this condition, although specific roles for liver biopsy still remain particularly in the s...
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Korean Association for the Study of the Liver
2015-09-01
|
| Series: | Clinical and Molecular Hepatology |
| Subjects: | |
| Online Access: | http://e-cmh.org/upload/pdf/cmh-21-212.pdf |
| _version_ | 1817997452018450432 |
|---|---|
| author | Vijay H. Shah |
| author_facet | Vijay H. Shah |
| author_sort | Vijay H. Shah |
| collection | DOAJ |
| description | Alcoholic liver disease continues to be a significant cause of liver-related morbidity and mortality throughout the world. A number of diagnostic and prognostic models have been developed in the management of this condition, although specific roles for liver biopsy still remain particularly in the setting of alcoholic hepatitis. Despite a large number of recent treatment trials, the ideal pharmacotherapy approach remains undefined. Most essential is the supportive care and focus on abstinence and nutrition. Owing in part to a great deal of attention from governmental funding sources, a number of new treatment approaches are undergoing rigorous evaluation, hopefully providing future treatment options in this very severe condition. |
| first_indexed | 2024-04-14T02:38:24Z |
| format | Article |
| id | doaj.art-f849860114314fe58273834682b100db |
| institution | Directory Open Access Journal |
| issn | 2287-2728 2287-285X |
| language | English |
| last_indexed | 2024-04-14T02:38:24Z |
| publishDate | 2015-09-01 |
| publisher | Korean Association for the Study of the Liver |
| record_format | Article |
| series | Clinical and Molecular Hepatology |
| spelling | doaj.art-f849860114314fe58273834682b100db2022-12-22T02:17:17ZengKorean Association for the Study of the LiverClinical and Molecular Hepatology2287-27282287-285X2015-09-0121321221910.3350/cmh.2015.21.3.2121140Managing alcoholic liver diseaseVijay H. Shah0Gastroenterology Research Unit, Department of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN, USA.Alcoholic liver disease continues to be a significant cause of liver-related morbidity and mortality throughout the world. A number of diagnostic and prognostic models have been developed in the management of this condition, although specific roles for liver biopsy still remain particularly in the setting of alcoholic hepatitis. Despite a large number of recent treatment trials, the ideal pharmacotherapy approach remains undefined. Most essential is the supportive care and focus on abstinence and nutrition. Owing in part to a great deal of attention from governmental funding sources, a number of new treatment approaches are undergoing rigorous evaluation, hopefully providing future treatment options in this very severe condition.http://e-cmh.org/upload/pdf/cmh-21-212.pdfLiver transplantationAlcoholic hepatitisCorticosteroidsAlcohol |
| spellingShingle | Vijay H. Shah Managing alcoholic liver disease Clinical and Molecular Hepatology Liver transplantation Alcoholic hepatitis Corticosteroids Alcohol |
| title | Managing alcoholic liver disease |
| title_full | Managing alcoholic liver disease |
| title_fullStr | Managing alcoholic liver disease |
| title_full_unstemmed | Managing alcoholic liver disease |
| title_short | Managing alcoholic liver disease |
| title_sort | managing alcoholic liver disease |
| topic | Liver transplantation Alcoholic hepatitis Corticosteroids Alcohol |
| url | http://e-cmh.org/upload/pdf/cmh-21-212.pdf |
| work_keys_str_mv | AT vijayhshah managingalcoholicliverdisease |